SPRY — SILVERBACK THERAPEUTICS INC

Ownership history in ORBIMED ADVISORS LLC  ·  21 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in SILVERBACK THERAPEUTICS INC (SPRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.61% (2025 Q2)
Avg. % of fund
1.72%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 8,288,510 — 0% 1.97% $96.6M $11.65
2025 Q3 UNCHANGED 8,288,510 — 0% 1.96% $83.3M $10.05
2025 Q2 UNCHANGED 8,288,510 — 0% 3.61% $144.6M $17.45
2025 Q1 UNCHANGED 8,288,510 — 0% 2.49% $104.3M $12.58
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SPRY price (monthly, adj. close)

Other funds also holding SPRY

As of 2025 Q4 — sorted by position size

SR ONE CAPITAL MANAGEMENT, LP 3Y 6.62% Tyro Capital Management LLC 4.16% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.3% Casdin Capital, LLC 3Y 7Y 1.16% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.12% Lisanti Capital Growth, LLC 3Y 7Y 1.09% INVESTMENT MANAGEMENT ASSOCIATES INC /ADV 3Y 1.0% Rubric Capital Management LP 3Y 7Y 0.86% LEVIN CAPITAL STRATEGIES, L.P. 3Y 7Y 0.75% DAFNA Capital Management LLC 3Y 7Y 0.51%
← Back to ORBIMED ADVISORS LLC Holdings